This intricate interplay of effects uncovers previously unexplored facets of the KISS1R agonist’s impact on CKD-related parameters, furthering our understanding of the mechanisms contributing to uremic cardiomyopathy. This evidence concerns the gene KISS1R and chronic kidney disease.